Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

Fair Value Measurements (Tables) - Warrants to Purchase Common Stock [Member]

9 Months Ended

Sep. 30, 2023

Schedule of revaluation of warrant liability


		Warrants
($ in thousands)		liabilities
Balance at December 31, 2022		$	13,869
Avenue common stock warrants			2,235
Urica placement agent warrants			33
Change in fair value of common stock warrants - Avenue			(1,544)
Change in fair value of common stock warrants - Checkpoint			(9,179)
Change in fair value of placement agent warrants - Urica			16
Balance at September 30, 2023		$	5,430

Checkpoint Common Stock Warrants

Schedule of revaluation of warrant liability


		Checkpoint
		Warrant
($ in thousands)		Liability
Common Stock Warrant liabilities at December 31, 2022		$	11,170
Change in fair value of common stock warrant liabilities			(9,179)
Common Stock Warrant liabilities at September 30, 2023		$	1,991

Summary of the Weighted average Significant Unobservable Inputs


		September 30,				December 31,
Checkpoint Warrants		2023				2022
Exercise price		$	4.08 - 5.41			$	4.08 - 5.41
Volatility			91.4 - 102.8	%			82.4 - 89.4	%
Expected life			0.7 - 4.2				1.5 - 5.0
Risk-free rate			4.6 - 5.5	%			4.0 - 4.7	%

Avenue Therapeutics, Inc [Member]

Schedule of revaluation of warrant liability


		Avenue
		Warrant
($ in thousands)		Liability
Common Stock Warrant liabilities at December 31, 2022		$	2,609
Issuance of Avenue common warrants			2,235
Change in fair value of common stock warrant liabilities			(1,544)
Common Stock Warrant liabilities at September 30, 2023		$	3,300

Summary of the Weighted average Significant Unobservable Inputs


		September 30,			January 31			December 31
		2023			2023			2022
Stock price		$ 0.71			$ 1.38			$ 1.16
Risk-free interest rate		4.60 - 5.03	%		3.90	%		4.02	%
Expected dividend yield		—			—			—
Expected term in years		2.4 - 4.0			3.00			4.78
Expected volatility		141 - 165	%		160	%		93	%

Summary of the Weighted average Significant Unobservable Inputs


		September 30,			December 31
		2023			2022
Risk-free interest rate		5.50	%		3.94	%
Expected dividend yield		—			—
Expected term in years		0.8			1.5
Expected volatility		85.7	%		70.7	%